Tuesday, November 23, 2021 2:23:22 PM
I made a quick flip this morning but honestly didn't expect it to go as high as it did. Thinking about jumping back in but not sure.
Thoughts?
Recent KTTA News
- Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 04/29/2024 11:59:00 AM
- Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers • GlobeNewswire Inc. • 04/24/2024 11:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 02:46:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 02:46:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 02:45:45 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 02:45:23 AM
- Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004 • GlobeNewswire Inc. • 02/13/2024 12:59:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:30:41 PM
- Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position • GlobeNewswire Inc. • 01/08/2024 12:59:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:47:43 PM
- Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients • GlobeNewswire Inc. • 01/02/2024 01:35:05 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/28/2023 10:00:30 PM
- Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023 • GlobeNewswire Inc. • 12/28/2023 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:30:10 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2023 10:26:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 10:21:07 PM
- Pasithea Therapeutics Announces Results from 2023 Annual Meeting • GlobeNewswire Inc. • 12/19/2023 10:19:00 PM
- Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models • GlobeNewswire Inc. • 12/11/2023 01:01:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/29/2023 10:00:00 PM
- Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders • GlobeNewswire Inc. • 11/29/2023 09:27:00 PM
- Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development • GlobeNewswire Inc. • 11/29/2023 12:59:00 PM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM